Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AURA |
---|---|---|
09:32 ET | 1732 | 7.86 |
09:38 ET | 100 | 7.68 |
09:41 ET | 2311 | 7.655 |
09:43 ET | 599 | 7.52 |
09:48 ET | 400 | 7.45 |
09:50 ET | 200 | 7.46 |
09:52 ET | 100 | 7.49 |
09:54 ET | 200 | 7.495 |
09:57 ET | 100 | 7.41 |
10:01 ET | 400 | 7.32 |
10:03 ET | 100 | 7.38 |
10:06 ET | 100 | 7.3875 |
10:08 ET | 200 | 7.38 |
10:10 ET | 300 | 7.3801 |
10:12 ET | 100 | 7.38 |
10:14 ET | 2445 | 7.485 |
10:24 ET | 1044 | 7.565 |
10:30 ET | 7200 | 7.63 |
10:32 ET | 6885 | 7.67 |
10:35 ET | 3159 | 7.7 |
10:39 ET | 1435 | 7.64 |
10:44 ET | 200 | 7.6 |
10:48 ET | 4517 | 7.715 |
10:51 ET | 1100 | 7.71 |
10:53 ET | 200 | 7.7 |
10:55 ET | 500 | 7.71 |
10:57 ET | 100 | 7.71 |
11:00 ET | 5471 | 7.725 |
11:02 ET | 200 | 7.7 |
11:04 ET | 400 | 7.7 |
11:06 ET | 2202 | 7.65 |
11:08 ET | 2958 | 7.71 |
11:09 ET | 608 | 7.73 |
11:11 ET | 250 | 7.745 |
11:13 ET | 100 | 7.745 |
11:15 ET | 129 | 7.7627 |
11:22 ET | 300 | 7.77 |
11:24 ET | 300 | 7.745 |
11:26 ET | 100 | 7.78 |
11:27 ET | 100 | 7.765 |
11:29 ET | 100 | 7.75 |
11:33 ET | 100 | 7.745 |
11:38 ET | 229 | 7.75 |
11:40 ET | 1300 | 7.81 |
11:45 ET | 300 | 7.81 |
12:00 ET | 741 | 7.77 |
12:02 ET | 200 | 7.805 |
12:05 ET | 200 | 7.805 |
12:12 ET | 300 | 7.77 |
12:14 ET | 100 | 7.75 |
12:18 ET | 100 | 7.76 |
12:20 ET | 100 | 7.76 |
12:21 ET | 100 | 7.77 |
12:27 ET | 300 | 7.76 |
12:30 ET | 100 | 7.75 |
12:32 ET | 200 | 7.775 |
12:36 ET | 320 | 7.765 |
12:38 ET | 200 | 7.74 |
12:41 ET | 224 | 7.71 |
12:45 ET | 200 | 7.74 |
12:50 ET | 100 | 7.71 |
12:52 ET | 100 | 7.74 |
12:54 ET | 100 | 7.715 |
12:56 ET | 200 | 7.74 |
12:57 ET | 100 | 7.715 |
12:59 ET | 100 | 7.735 |
01:01 ET | 100 | 7.745 |
01:03 ET | 4058 | 7.85 |
01:12 ET | 254 | 7.82 |
01:14 ET | 1100 | 7.85 |
01:26 ET | 200 | 7.75 |
01:30 ET | 200 | 7.76 |
01:32 ET | 100 | 7.75 |
01:33 ET | 2825 | 7.85 |
01:42 ET | 200 | 7.81 |
01:46 ET | 100 | 7.83 |
01:50 ET | 100 | 7.825 |
01:53 ET | 200 | 7.82 |
01:55 ET | 100 | 7.827 |
01:57 ET | 100 | 7.81 |
02:00 ET | 200 | 7.81 |
02:02 ET | 200 | 7.8 |
02:04 ET | 700 | 7.84 |
02:09 ET | 600 | 7.88 |
02:11 ET | 100 | 7.83 |
02:15 ET | 100 | 7.83 |
02:20 ET | 200 | 7.82 |
02:22 ET | 300 | 7.82 |
02:24 ET | 200 | 7.8 |
02:27 ET | 300 | 7.81 |
02:29 ET | 900 | 7.85 |
02:31 ET | 100 | 7.82 |
02:40 ET | 900 | 7.83 |
02:44 ET | 100 | 7.83 |
02:45 ET | 100 | 7.82 |
02:49 ET | 200 | 7.81 |
02:54 ET | 900 | 7.83 |
02:56 ET | 1300 | 7.89 |
02:58 ET | 252 | 7.8932 |
03:00 ET | 1000 | 7.88 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Aura Biosciences Inc | 378.0M | -4.0x | --- |
ESSA Pharma Inc | 378.7M | -14.5x | --- |
Third Harmonic Bio Inc | 382.2M | -9.1x | --- |
Corbus Pharmaceuticals Holdings Inc | 373.2M | -3.8x | --- |
Fibrobiologics Inc | 383.5M | -12.0x | --- |
Kodiak Sciences Inc | 390.9M | -1.1x | --- |
Aura Biosciences, Inc. is a clinical-stage biotechnology company focused on developing virus-like drug conjugates (VDCs), a novel class of therapies for the treatment of multiple oncology indications. The Company’s lead VDC candidate, AU-011 (belzupacap sarotalocan), consists of a virus-like particle conjugated with an anti-cancer agent. AU-011 consists of human papillomavirus (HPV)-derived VLP conjugated to hundreds of infrared laser-activated molecules. AU-011 selectively targets and destroys cancer cells and activates the immune system with the potential to create long-lasting anti-tumor immunity. AU-011 is in development for ocular cancers and has initiated activities for the global Phase III trial evaluating first-line treatment of early-stage choroidal melanoma. It seeks to develop AU-011 across its ocular oncology franchise. In addition, the Company is developing AU-011 across multiple cancers, including in patients with non-muscle invasive bladder cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $378.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 49.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.95 |
Book Value | $5.18 |
P/E Ratio | -4.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.